Keiko Funahashi

Efficacy of tocilizumab and evaluation of clinical remission as determined by CDAI and MMP-3 level

Keiko Funahashi, Satoru Koyano, Takako Miura et al. · Modern Rheumatology · 2009 · 41 citations

Life Sciences, Immunology, Pharmacotherapy +17

Efficacy of tocilizumab and evaluation of clinical remission as determined by CDAI and MMP-3 level

Keiko Funahashi, Satoru Koyano, Takako Miura et al. · Modern Rheumatology · 2009 · 29 citations

Life Sciences, Immunology, Pharmacotherapy +17

ARG098, a novel anti-human Fas antibody, suppresses synovial hyperplasia and prevents cartilage destruction in a severe combined immunodeficient-HuRAg mouse model

Noriko Odani‐Kawabata, Miwa Takai-Imamura, Osamu Katsuta et al. · BMC Musculoskeletal Disorders · 2010 · 15 citations · Full text

Life Sciences, Cell Biology, Immunology +16

A genome‑wide association study identifying the SNPs predictive of rapid joint destruction in patients with rheumatoid arthritis

Shinya Hayashi, Tsukasa Matsubara, Koji Fukuda et al. · Biomedical Reports · 2021 · 12 citations · Full text

Life Sciences, Genetics, Molecular Genetics +17

The usefulness of a new triple combination treatment utilizing methotrexate, salazosulfapyridine, and bucillamine in rheumatoid arthritis

Hiroaki Matsuno, Masato Okada, Yoshitada Sakai et al. · Modern Rheumatology · 2015 · 11 citations

Medicine, Internal Medicine, Pharmacotherapy +12